跳至主要内容
临床试验/NCT03148964
NCT03148964招募中不适用

Multicentric Cohort of HIV-1 (Human Immunodeficiency Virus 1) Primary Infection Cohort ANRS CO6 PRIMO

ANRS, Emerging Infectious Diseases1 个研究点 分布在 1 个国家目标入组 2,800 人开始时间: 1996年10月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,800
试验地点
1
主要终点
Improve the physiological, pathological and virological knowledge of primary HIV infection

研究概览

简要总结

Open, prospective, multicenter French cohort study enrolling subjects aged of 15 years or more, during or immediately after HIV-1 primary infection. This cohort was organized from the outset to be highly multidisciplinary, bringing together immunologists, virologists, clinicians and epidemiologists.

详细描述

Objectives: Follow up of patients infected by HIV-1 for less than three months.

  1. Improve the physiological and pathological knowledge of primary HIV infection
  • Study of the immune mechanisms involved early after infection
  • Kinetics of viral replication and establishment of cellular reservoirs at an early stage
  • Relationships between virological markers and immune response kinetics
  • Impact of resistance mutations, subtype and tropism on the disease progression and the response to treatment
  • Study of sub-groups of specific patients followed since primary infection, spontaneous or post treatment controllers, subjects with specific HLA
  1. Assessing the impact of early, transient or prolonged treatment versus deferred treatment on the long-term prognosis of patients followed since primary infection, in terms of activation / inflammation and decrease in viral reservoirs
  2. Contribute to knowledge in the epidemiology of HIV infection:
  • Modes of transmission
  • Sexual behavior after HIV diagnosis
  • Calendar trend of transmitted viral strains diversity (ARV resistance and subtypes)
  • Calendar trend of marker levels measured at primary infection
  1. Contribute to national recommendations for therapeutic care, evaluate their implementation
  2. Use observational data from the cohort for the development of therapeutic clinical trials at primary infection

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • symptomatic or asymptomatic HIV-1 primary infection.
  • Infection date based on one of the following criteria:
  • Positive p24 antigenemia or detectable plasma HIV RNA with a negative ELISA within the previous six weeks.
  • Positive p24 antigenemia or detectable plasma HIV RNA with a positive ELISA and negative Western Blot within the previous six weeks.
  • Positive p24 antigenemia or detectable plasma HIV RNA or positive ELISA with incompleted Western Blot (no anti-p34 and/or anti-p68) within the previous six weeks.
  • Positive ELISA with a negative ELISA within the last three months.
  • Age≥ 15 years old at the enrollment.
  • Naive of antiretroviral treatment except for transient treatment taken in the context of PMTCT, Pre-exposition prophylaxis or Post Exposition Prophylaxis.
  • Affiliate or beneficiary of a social security system (State Medical Assistance is not a social security scheme).

排除标准

  • Inability to give informed consent.
  • Predictable difficult follow-up.
  • Contraindication to repeated blood samples.
  • Under protection (saving) of justice
  • Life-threatening pathology (deferred inclusion is possible)

结局指标

主要结局

Improve the physiological, pathological and virological knowledge of primary HIV infection

时间窗: up to 25 years

* Study of the immune mechanisms involved early after infection * Kinetics of viral replication and establishment of cellular reservoirs at an early stage * Relationships between virological markers and immune response kinetics * Impact of resistance mutations, subtype and tropism on the disease progression and the response to treatment * Study of sub-groups of specific patients followed since primary infection, spontaneous or post treatment controllers, subjects with specific HLA

次要结局

  • Contribute to knowledge in the epidemiology of HIV infection(up to 25 years)
  • Contribute to national recommendations for therapeutic care and evaluate their implementation(up to 25 years)
  • The impact of early, transient or prolonged treatment versus deferred treatment on the long-term prognosis of patients followed since primary infection, in terms of activation / inflammation(up to 25 years)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验